In this issue:
Sovleplenib for chronic primary ITP
Lenalidomide and dexamethasone for Rosai-Dorfman disease
Decision support system for optimal allogeneic SCT timing in MDS
Induction course number for attaining CR in transplanted AML
Iron, haemochromatosis genotypes and infection risk
Mavorixafor for WHIM syndrome
Ivosidenib for IDH1-mutated relapsed/refractory MDS
Outcome of primary HLH
Ixazomib-cyclophosphamide-dexamethasone for newly diagnosed POEMS syndrome
DVD in relapsed/refractory light-chain amyloidosis after initial bortezomib
Expert contributor
Professor Jeff Szer AM (@marrow), is a member of the Clinical Haematology team at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital. He is also Director of the Western and Central Melbourne Integrated Cancer Service and outgoing President of the World Marrow Donor Association. He established the first adult bone marrow transplant centre in […]
Stay up to date with our latest clinical information.
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.